Literature DB >> 25899394

Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34(+) cells.

Zheng Du1, Ziyan Wang, Weiwei Zhang, Haibo Cai, Wen-Song Tan.   

Abstract

OBJECTIVES: Stem cell factor (SCF) is essential in the haematopoietic stem cells (HSCs) niche, and is therefore used extensively in haematopoietic stem and progenitor cells (HSPCs) ex vivo expansion. However, in the literature, dose and schedule of SCF feeding varies widely. We previously proposed a novel SCF feeding regimen with proven effectiveness for HSPCs expansion; however, physiological function of expanded cells with this SCF feeding regimen required further research.
MATERIALS AND METHODS: CD34(+) cells were cultured with or without SCF supplementation in serum-free medium for 10 days. Expanded cells were transplanted into sublethally irradiated non-obese diabetic/severe combined immune-deficient (NOD/SCID) mice. Engraftment and multilineage reconstitution of transplanted cells were determined. Also, clonogenic potential of engrafted cells was analysed.
RESULTS: Cells, both cultured with and without SCF supplementation, successfully engrafted and reconstituted blood cell lineages in NOD/SCID mice. However, level of engraftment and multilineage reconstitution reduced when cells were expanded without SCF supplementation. Meanwhile, frequencies of colony-forming cells (CFCs) amongst bone marrow cells were higher in mice transplanted with CD34(+) cells expanded with SCF supplementation.
CONCLUSIONS: Reconstitution capacity reduced when CD34(+) cells were expanded without SCF supplementation, though this feeding regimen did not have any effect on cell expansion. This finding suggested that SCF was essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded CD34(+) cells.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25899394      PMCID: PMC6496601          DOI: 10.1111/cpr.12186

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  28 in total

1.  Systematic investigation of oxygen and growth factors in clinically valid ex vivo expansion of cord blood CD34(+) hematopoietic progenitor cells.

Authors:  Melinda L Tursky; Fiona M Collier; Alister C Ward; Mark A Kirkland
Journal:  Cytotherapy       Date:  2012-03-16       Impact factor: 5.414

2.  Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties.

Authors:  Michelle B Bowie; David G Kent; Brad Dykstra; Kristen D McKnight; Lindsay McCaffrey; Pamela A Hoodless; Connie J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-22       Impact factor: 11.205

Review 3.  Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway.

Authors:  David Kent; Michael Copley; Claudia Benz; Brad Dykstra; Michelle Bowie; Connie Eaves
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

4.  Milestones in umbilical cord blood transplantation.

Authors:  Eliane Gluckman; Annalisa Ruggeri; Fernanda Volt; Renato Cunha; Karim Boudjedir; Vanderson Rocha
Journal:  Br J Haematol       Date:  2011-07-05       Impact factor: 6.998

Review 5.  Stem cell bioengineering strategies to widen the therapeutic applications of haematopoietic stem/progenitor cells from umbilical cord blood.

Authors:  Pedro Z Andrade; Francisco dos Santos; Joaquim M S Cabral; Cláudia L da Silva
Journal:  J Tissue Eng Regen Med       Date:  2013-04-08       Impact factor: 3.963

6.  Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells.

Authors:  Ewa Sitnicka; Natalija Buza-Vidas; Staffan Larsson; Jens M Nygren; Karina Liuba; Sten Erik W Jacobsen
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

Review 7.  An overview of the progress on double umbilical cord blood transplantation.

Authors:  Anastasia Sideri; Nikolaos Neokleous; Philippe Brunet De La Grange; Bernadette Guerton; Marie-Caroline Le Bousse Kerdilles; Georges Uzan; Corina Peste-Tsilimidos; Eliane Gluckman
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

8.  Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Authors:  Colleen Delaney; Shelly Heimfeld; Carolyn Brashem-Stein; Howard Voorhies; Ronald L Manger; Irwin D Bernstein
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

9.  Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.

Authors:  Yoshikane Kikushige; Goichi Yoshimoto; Toshihiro Miyamoto; Tadafumi Iino; Yasuo Mori; Hiromi Iwasaki; Hiroaki Niiro; Katsuto Takenaka; Koji Nagafuji; Mine Harada; Fumihiko Ishikawa; Koichi Akashi
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

10.  Optimization of SCF feeding regimen for ex vivo expansion of cord blood hematopoietic stem cells.

Authors:  Zheng Du; Haibo Cai; Zhaoyang Ye; Wen-Song Tan
Journal:  J Biotechnol       Date:  2012-08-29       Impact factor: 3.307

View more
  3 in total

1.  Curved microstructures promote osteogenesis of mesenchymal stem cells via the RhoA/ROCK pathway.

Authors:  Qi Zhang; Shiyu Lin; Tao Zhang; Taoran Tian; Quanquan Ma; Xueping Xie; Changyue Xue; Yunfeng Lin; Bofeng Zhu; Xiaoxiao Cai
Journal:  Cell Prolif       Date:  2017-08       Impact factor: 6.831

2.  Sustained release of stem cell factor in a double network hydrogel for ex vivo culture of cord blood-derived CD34+ cells.

Authors:  Yuanhao Zhang; Xiuwei Pan; Zhen Shi; Haibo Cai; Yun Gao; Weian Zhang
Journal:  Cell Prolif       Date:  2017-11-15       Impact factor: 6.831

3.  Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.

Authors:  Qiuyang Li; Dewan Zhao; Qiang Chen; Maowen Luo; Jingcao Huang; Cao Yang; Fangfang Wang; Wenxian Li; Ting Liu
Journal:  Stem Cell Res Ther       Date:  2019-12-05       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.